Related Experiment Videos
ECMO support in a child with acute fulminant myocarditis
Wei Hu1, Shujiong Mao, Weihang Hu
1Intensive Care Unit, The First People's Hospital of Hangzhou, Hangzhou 310006, China.
Indian Journal of Pediatrics
|October 13, 2010
Summary
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) successfully treated a pediatric patient with acute fulminant myocarditis unresponsive to conventional therapy. VA-ECMO improved cardiac function and hemodynamics, enabling successful weaning and hospital discharge.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Cardiovascular Surgery
Background:
- Acute fulminant myocarditis is a severe inflammation of the heart muscle, often leading to hemodynamic instability in children.
- Conventional medical therapies, including antibiotics and vasoactive agents, may be insufficient for severe cases.
Observation:
- An 11-year-old boy with acute fulminant myocarditis showed clinical deterioration despite 5 days of standard medical treatment.
- Venoarterial extracorporeal membrane oxygenation (VA-ECMO) was initiated 39 hours after intensive care unit admission.
Findings:
- Following VA-ECMO initiation, significant improvements in urine output and blood pressure were observed within 24 hours.
- After 140 hours of VA-ECMO support, the patient's ejection fraction increased to 45%, blood pressure normalized, and urine output stabilized.
- The patient was successfully weaned from VA-ECMO, with ejection fraction improving to 72% by hospital discharge on day 23.
Implications:
- VA-ECMO serves as a critical life-saving intervention for pediatric patients with acute fulminant myocarditis refractory to medical management.
- Early initiation of VA-ECMO can lead to favorable outcomes, including recovery of cardiac function and successful patient discharge.
- This case highlights the efficacy of VA-ECMO in managing severe pediatric myocarditis, offering a bridge to recovery or definitive treatment.
Related Concept Videos
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...